Skip to main content

Table 1 Clinical characteristics of 41 patients

From: MicroRNA-136-3p inhibits glioma tumorigenesis in vitro and in vivo by targeting KLF7

Clinicopathologic feature n (%) miR-136-3p p value
High Low mean ± SEM
Age      p = 0.3603
 ≤ 40 19 (46.34%) 10 9 1.89 ± 0.18  
 ≥ 40 22 (53.66%) 10 12 1.92 ± 0.17  
Gender      p = 0.2104
 Female 18 (43.90%) 8 10 1.91 ± 0.19  
 Male 24 (56.10%) 13 11 1.79 ± 0.18  
Surgery      p = 0.4472
 Biopsy 7 (17.07%) 4 3 2.03 ± 0.20  
 Partial resection 14 (34.15%) 5 9 2.15 ± 0.18  
 Gross total resection 20 (48.78%) 9 11 2.07 ± 0.21  
WHO grade (%)      p < 0.0001
 ІІ 8 (30.00%) 2 6 2.91 ± 0.26  
 ІІІ 12 (33.33%) 4 8 2.05 ± 0.21  
 IV 21 (36.67%) 5 17 1.68 ± 0.17  
Low expression 18 (43.90%) 13 5 4.19 ± 0.41 p < 0.0001
High expression 23 (56.10%) 4 19 1.98 ± 0.22  
Tumor size      p = 0.3514
 < 4 cm 16 (39.02%) 7 8 2.18 ± 0.21  
 ≥ 4 cm 25 (60.98%) 11 14 2.24 ± 0.23